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a b s t r a c t
EmrE is a member of the small multidrug resistance (SMR) protein family in Escherichia coli. EmrE
confers resistance to a wide variety of quaternary cation compounds (QCCs) as an efﬂux transporter
driven by proton motive force. The puriﬁcation yield of most membrane proteins are challenging
because of difﬁculties in over expressing, isolating and solubilizing them and the addition of an afﬁnity
tag often improves puriﬁcation. The purpose of this study is to compare the structure and function of
hexahistidinyl (His6) tagged (T-EmrE) and untagged (UT-EmrE) versions of EmrE. In vivo QCC resistance
assays determined that T-EmrE demonstrated reduced resistance as compared to UT-EmrE. We isolated
EmrE using the two different puriﬁcation methods, an organic solvent extraction method used to isolate
UT-EmrE and nickel afﬁnity chromatography of T-EmrE. All proteins were solubilized in the same
buffered n-dodecyl-β-D-maltopyranoside (DDM) detergent and their conformations were examined in
the presence/absence of different QCCs. In vitro analysis of protein multimerization using SDS-Tricine
PAGE and dynamic light scattering analysis revealed that both proteins predominated as monomers, but
the formation of dimers was more constant and uniform in T-EmrE compared to UT-EmrE. The aromatic
residue conformations of both proteins indicate that T-EmrE form is more aqueous exposed than UT-
EmrE, but UT-EmrE appeared to have a more dynamic environment surrounding its aromatic residues.
Using ﬂuorescence to obtain QCC ligand-binding curves indicated that the two forms had differences in
dissociation constants (Kd) and maximum speciﬁc one-site binding (Bmax) values for particular QCCs.
In vitro analyses of both proteins demonstrated subtle but signiﬁcant differences in multimerization and
QCC binding. In vivo analysis indicates differences caused by the addition of the tag, we also observed
differences in vitro that could be a result of the tag and/or the different puriﬁcation methods.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Escherichia coli multidrug resistance transporter E (EmrE) is an
integral membrane protein that is 110 amino acids in length and is
considered to be the archetypical member of the small multidrug
resistance (SMR) family transporters [1,2]. EmrE is one of many
transporters responsible for antiseptic drug resistance in bacteria
by the efﬂux of toxic quaternary cationic compounds (QCCs) [3,4].
EmrE is composed of 4 transmembrane spanning alpha helices
connected by short loops (as reviewed by Bay et al. [2]). EmrE has
been shown to exist as a monomer, dimer, trimer, tetramer or even
higher ordered multimers/complexes but the minimal functional
unit is considered to be a dimer [5–9].
Due to the high proportion of hydrophobic residues in EmrE, it
can partition into and be puriﬁed from organic solvents. Initial
studies of EmrE involved an organic solvent mixture of 1:1
chloroform:methanol to extract and isolate EmrE from E. coli
membranes [3]. Following organic extraction, lipophilic chromato-
graphy techniques were used for the puriﬁcation of EmrE [10].
Another puriﬁcation method involved the fusion of a hexahistidine
(His6) tag onto the C-terminus to purify EmrE using immobilized
Ni2þ afﬁnity chromatography techniques [11]. This His6 modiﬁca-
tion is commonly used in most structural analyses of EmrE protein
(as reviewed by Bay et al. [2]). However, the inﬂuence of the His6
tag on structure and activity can depend on the position of its
attachment to the protein [12]. Almost all tagged EmrE protein
in vitro studies have involved a fusion tag that includes a myc
epitope linker attached to the His6 sequence on the C-terminus
(EmrE-myc-His6), which was shown to improve protein expression
and functional activity (as described by Muh and Schuldiner [5]).
Since its publication, this EmrE-myc-His6 tagged version has been
used to study the biochemistry and biophysical conformation of
EmrE protein over the past decade.
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The primary sequences of previously characterized untagged
(UT-) and tagged (T-) EmrE are shown in Fig. 1. T-EmrE has been
extensively studied structurally and biochemically and serves as
the model SMR family protein [13]. High-resolution 3D analysis
using cryo-electron microscopy and X-ray diffraction crystallogra-
phy has reported the conformational state of asymmetric dimer
for T-EmrE [8,14,15]. NMR studies of T-EmrE have also shown that
it forms a functional dimer, where both Glu14 ligand binding
active site residues from each monomer were located in structu-
rally inequivalent environments [16]. In addition to Glu14, pre-
vious studies of T-EmrE have identiﬁed the involvement of
aromatic residues in ligand binding. Trp63 was demonstrated to
be located close to the QCC binding pocket and deemed important
for ligand binding as a mutation at this position abolished
substrate binding [4,17]. Two other tryptophans located within
transmembrane segments 2 and 3 and the fourth tryptophan can
be found in loop 2 of both proteins, however both UT- and T-EmrE
also have 5 and 6 tyrosines respectively. Although the majority of
published work on EmrE has focused on T-EmrE and to a lesser
extent UT-EmrE (as reviewed by Bay et al. [2]), a direct comparison
between both forms of the protein have never performed. Con-
founding and sometimes conﬂicting EmrE ligand binding data
[5,7,14,18–20] provided in Table 1 that highlights the differences
in ligand binding constants of T-EmrE and UT-EmrE.
The goal of this study was to compare UT-EmrE and T-EmrE
preparations analyzed under the same detergent conditions using
the same biochemical and biophysical techniques to identify the
similarities and differences between their structures and func-
tions. The aim of this study was to compare EmrE proteins isolated
using their respective puriﬁcation methods as reported for UT-
EmrE [9,21] and for T-EmrE [22] in side by side in the same in vivo
and in vitro experiments. The outcome will ideally resolve some of
the differences that have been reported between different groups.
A comparison of in vivo QCC resistance for the two forms revealed
different resistance proﬁles. Upon puriﬁcation, UT-EmrE and
T-EmrE were reconstituted into the same buffer conditions con-
taining 0.08% w/v n-dodecyl-β-D-maltopyranoside (DDM). Four
different but commonly examined QCCs were selected for testing
UT-EmrE and T-EmrE. Both forms of the protein were evaluated
using Sodium dodecyl sulfate (SDS)-Tricine polyacrylamide gel
electrophoresis (PAGE), dynamic light scattering (DLS) and ﬂuor-
escence spectroscopy. SDS-Tricine PAGE and DLS techniques were
used to compare the size and multimeric state of both proteins.
Intrinsic Trp ﬂuorescence analysis was used to determine changes
in the environment of tryptophans and tyrosines, as they provide
insight into chemistry of their immediate surroundings and
excited state and relaxation dynamics of the protein. Changes in
ﬂuorescence emission maximum and intensity by both versions of
the protein were also compared to determine any differences in
Trp quenching caused by QCC binding in the protein. Using the
same membrane mimetic detergent solubilization conditions, the
in vitro comparison of UT-EmrE and T-EmrE in 0.08% w/v DDM
reﬂected subtle differences in how each protein interacted with
itself as a multimer and with each of the four QCCs tested. The
aromatic residue conformations of both proteins indicate that T-
EmrE form is more open to aqueous than UT-EmrE, but UT-EmrE
has multiple environments surrounding its aromatic residues
suggesting more dynamics. Fluorescent ligand binding experi-
ments performed with UT-EmrE and T-EmrE also determined that
the tag may provide a conformation that restricts the binding of
certain QCC. This study highlights the subtle variations in function
and conformation of EmrE.
2. Material and methods
2.1. Materials
The chemicals used in this study were purchased from either
Sigma Aldrich (St. Louis, MO, USA) or EMD Chemicals (Darmstadt,
Germany). Electrophoresis equipment and electrophoretic chemi-
cals were obtained from BioRad (Hercules, CA, USA). The DDM
detergent, used for protein solubilization and spectroscopy was
purchased from Affymetrix-Anatrace (Santa Clara, CA, USA).
2.2. In vivo E. coli QCCs resistance assays of UT-EmrE and T-EmrE
Both UT-EmrE and T-EmrE were cloned in the expression vector
pMS119EH resulting in the plasmids pEmr11 and pEmrEmLVH6,
respectively. Both genes were expressed with this vector using the
isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible tac promo-
ter and permitted the expression of both constructs under iden-
tical conditions. Expression of either EmrE construct was not
induced by IPTG nor was it added to the growth media during
any resistance assays. Previous studies conﬁrmed that the expres-
sion ‘leakiness’ from the pMS119EH Ptac was appropriate for
biological assays of EmrE [23,24].
Fig. 1. (a) UT-EmrE and (b) T-EmrE amino acid sequences that were examined in this study. Boxes indicated predicted transmembrane regions for each protein.
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E. coli cells were cultured on a LB streak plate containing
0.1 mg/mL ampicillin. Colonies were picked and mixed into a
0.9% saline solution until the turbidity matched a 1.0 Mcfarland
standard. The solution was then used to inoculate 96-well plates
containing LB growth media. A dilution series of QCCs, ethidium
bromide (EB), methyl viologen (MV), cetylpyridinium chloride
(CTP) and tetraphenyl phosphonium (TPP) were prepared. QCC
serial dilutions started at a concentration of 5 mg/mL in a well up
to 9.8 μg/mL, using a 1/2 dilution step in each preceding well.
A well without QCC was also included as a growth control. Spot
plates containing LB and 0.1 mg/mL ampicillin were used to verify
the cell numbers estimated by the 1.0 Mcfarland standard. Spot
plates were incubated for 12–16 h at 37 1C before counting
colonies. Growth plates were incubated at 37 1C and removed
from the incubator every hour for 11 h to record the optical
densities (OD) of each well at 550 nm (OD550 nm) using a microtiter
plate reader. Plates were incubated at 37 1C for an additional 26 h
after inoculation and its OD550 nm was recorded. A series of “blank”
wells containing only growth media or growth media and QCC was
included on the plates for the background subtraction from the
sample. Data were collected and averaged over 3 biological repli-
cates. The result of this approach is a viability kill curve titration.
2.3. Expression and puriﬁcation of UT- and T-EmrE proteins
A brief description on the expression and puriﬁcation proce-
dure for both UT- and T-EmrE is provided in the following sections.
2.3.1. UT-EmrE protein accumulation, organic extraction and reverse
phase HPLC puriﬁcation
The expression and puriﬁcation of UT-EmrE were performed
using the procedure described previously [9]. Brieﬂy, LE392Δunc
cells containing the pEmrE11 plasmid were cultured in 1 L batches
of terriﬁc broth (TB) (12 g/L tryptone, 24 g/L yeast extract, 0.4% v/v
glycerol). Each 1 L culture batch was inoculated with 10 mL of
overnight culture in Lysogeny broth (LB) (10 g/L tryptone, 5 g/L
yeast extract, 5 g/L NaCl). All cultures contained 0.1 mg/mL ampi-
cillin to maintain the plasmids during cell growth. The cultures
were incubated at 37 1C and growth were monitored using
OD600 nm measurements. Once the OD600 nm of the cultures
reached between 0.5 and 0.7 (approximately 3 h), IPTG was added
to the ﬁnal concentration of 0.1 mM. Cultures were incubated at
37 1C in a shaking incubator for another 3 h. Cells were harvested
and washed in SMR-A buffer (50 mM MOPS, pH 7.5, 5 mM EDTA,
1 mM DTT, 8% w/v glycerol) by stirring. The cells were re-pelleted
by centrifugation at 4000g for 10 min at 4 1C and the supernatant
was discarded. Cell yield was 4 g per 1 L batch of culture that
was re-suspended in 1–2 mL of SMR-A buffer per gram of the wet
cell weight and stored frozen at −80 1C. Frozen cell suspensions
were thawed on ice and a serine protease inhibitor phenylmethyl
sulphonylﬂuoride (PMSF) was added to a ﬁnal concentration of
0.1 mM and passed through the French Press twice at 10,000 psi to
lyse the cells at 4 1C. Unbroken cells were separated by centrifuga-
tion at 2000g for 10 min and the supernatant was collected and
subjected to further centrifugation at 120,000g for 90 min at 4 1C
to collect the membrane pellet. The membrane pellet was re-
suspended by homogenization in SMR-A buffer and stored at –
80 1C.
The stored membrane sample was thawed and UT-EmrE
protein was extracted from the membrane by organic extraction
in 3:1 choroform:methanol solvent and concentrated using a
rotovap apparatus as described by Schwaiger et al. [10] and Butler
et al. [19]. The concentrated membrane organic extraction was
separated by reverse-phase fast pressure liquid chromatography
(FPLC) on AKTA™ Unicorn instrument (GE Lifesciences) using
SR10/25 column with LH20 sephadex resin in 1:1 chloroform:
methanol solvent. UT-EmrE protein eluted within the ﬁrst peak as
monitored by UV absorption at 280 nm (A280 nm) and SDS-Tricine
PAGE analysis of fractions. UT-EmrE protein fractions were pooled
together and dried under N2 gas before storing at –20 1C. Proteins
in each dried tube were collected from 3 L of cultures.
2.3.2. UT-EmrE protein solubilization in buffer containing DDM
detergent
Dried UT-EmrE proteins were solubilized in a buffer containing
DDM (20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 0.08% w/v DDM).
1 mL of the buffer was added to each tube of dried UT-EmrE
proteins. The suspension was vortexed for 2 h at room tempera-
ture and then centrifuged at 14,000g for 10 min to remove
insoluble material. The pellet was discarded and the protein
Table 1
Binding afﬁnities of QCCs to tagged and untagged EmrE evaluated under different conditions from previous studies.
Assaying condition Experiment Ligand Kd (μM) Reference
T-EmrE
0.08% w/v DDM Equilibrium dialysis [3H] TPP 0.0170.003 [5]
0.8% w/v DDM Saturation binding assay [3H] TPP 0.002870.001 [18]
0.1% w/v DDM Saturation binding assay [3H] TPP 0.002670.0004 [14]
0.5% w/v DDM (delipidated EmrE) Saturation binding assay [3H] TPP 2.570.5 [19]
0.5% w/v DDM (non-delipidated EmrE) 1072
UT-EmrE
Small unilamellar vesicle (SUV) Isothermal Titration Calorimetry (ITC) EB 5.572.1 [20]
MV 38.278.7
Pro 10.772.8
8% w/v SDS EB 5.271.4
MV 5.471.2
Pro 4.570.8
TPP 4.870.8
2% w/v DDM EB 6.371.0
MV 46.2710.5
Pro 5.270.9
TPP 25.576.2
2% w/v DDM Fluorescence EB 6.870.5 [7]
MV 43.673.8
TPP 23.677.1
CTP 6.672.2
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concentration of the supernatant was determined by a modiﬁed
Lowry assay [25]. The sample was then stored at –80 1C in small
aliquots for further analysis.
2.3.3. T-EmrE protein accumulation and puriﬁcation
The T-EmrE, containing EmrE with a myc epitope His6 tag as
described by Miroux and Walker [26] was cloned in the pTZ-19R
plasmid (pTZEmrEmH6). Plasmid encoded T-EmrE was expressed
in the E. coli strain C43(DE3) (F ompT hsdSB (rB– mB–) gal dcm
(DE3)). C43(DE3) cells containing the pTZEmrEmH6 plasmid were
cultured in 1 L batches of LB broth. Inoculation and initial growth
conditions were identical to UT-EmrE expression until each culture
reached an OD600 nm between 0.5 and 0.7 (approximately 4–5 h)
and were induced with 0.3 mM IPTG. Cultures were incubated for
an additional 3 h at 37 1C and then cells were harvested by
centrifugation using the same procedure as described for UT-
EmrE cultures. Harvested cells were stored in re-suspension buffer
(20 mM Tris–HCl, pH 8.2, 50 mM NaCl) and frozen at –80 1C. The
cell yield from this experiment was an average of 3.3 g per 1 L
batch of the culture.
T-EmrE was isolated in a similar manner to what was reported
by Miller et al. [22]. Frozen cells were thawed and lysed using a
French Press exactly as described for the UT-EmrE preparation and
membranes were isolated by the same UT-EmrE ultracentrifuga-
tion procedure. The T-EmrE containing membrane pellet obtained
from the 6 L culture was re-suspended in 25 mL of a membrane
solubilization buffer (40 mM Tris–HCl, pH 8.2, 100 mM NaCl, 4%
(w/v) DDM, 10 mM 2-mercaptoethanol). Re-suspended T-EmrE
containing membrane fractions were placed in 50 mL falcon tubes
for overnight on a gently rocking incubator at 4 1C to fully
solubilize all membrane proteins. The membrane protein disper-
sion was than ready for Ni2þ-afﬁnity resin chromatography.
2.3.4. T-EmrE-immobilized nickel afﬁnity chromatography
The membrane protein re-suspension from Section 2.3.3 was
diluted 1:1 with distilled H2O and centrifuged at 60,000g to pellet
non-solubilized material. NaCl to the ﬁnal concentrations of
350 mM and imidazole to 15 mM were added in the membrane
suspension after centrifugation. This sample was loaded into a
1 mL HisTrap FF immobilized nickel column (GE healthcare,
Canada) using an AKTA puriﬁer (GE healthcare) system for protein
isolation. After loading, the isolation conditions used to obtain
T-EmrE involved an initial washing step with 20 column volumes
(CV) of wash buffer (20 mM Tris–HCl, pH 8.3, 400 mM NaCl,
65 mM imidazole, 0.1% w/v DDM, 5 mM 2-mercaptoethanol) to
remove non-speciﬁc proteins. The ﬁnal step involved elution of the
protein from the resin with 10 CV of elution buffer (20 mM Tris–
HCl, pH 8.3, 25 mM NaCl, 200 mM imidazole, 0.1 % w/v DDM,
5 mM 2-mercaptoethanol). A single protein elution peak was
observed by monitoring the absorbance of the elutions at
280 nm and the corresponding elution fractions were collected
and desalted as described in Section 2.3.5.
2.3.5. T-EmrE HiTrap desalting chromatography
Eluted T-EmrE samples after Ni2þ-afﬁnity chromatography
were pooled together and 2 mL aliquots of the pooled sample
were injected into a 5 mL HiTrap desalting column (GE healthcare,
Canada) to remove the imidazole. The column was equilibrated
with DDM buffer (20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 0.08% w/v
DDM) and the sample was exchanged into this buffer. 0.08% w/v
DDM in this buffer corresponded to 1.6 mM DDM, which is well
above of its critical micelle concentration (CMC) of 0.12–0.17 mM
in the buffered solution. All of the eluted fractions were analyzed
by SDS-Tricine (12%T) PAGE to conﬁrm the presence and purity of
T-EmrE. The presence of T-EmrE was also conﬁrmed by Western
blotting the gels onto nitrocellulose and immunoblotting with
a conjugated anti-His6 Horseradish peroxidase antibody (Life
technologies, Canada). Desalted T-EmrE samples were pooled
together and stored at –80 1C until they were thawed for further
experiments.
2.4. UT-EmrE and T-EmrE protein concentration determination
The concentration of both puriﬁed proteins were determined
using a modiﬁed Lowry Assay [25] containing SDS to assist in
solubilizing membrane proteins. Serial dilutions of bovine serum
albumin (BSA) were used as a protein standard. The stock
concentration of reconstituted UT-EmrE in DDM and desalted
T-EmrE in DDM buffer was determined to be 15 mM and 11 mM
respectively.
2.5. SDS-Tricine PAGE analysis of UT-EmrE and T-EmrE proteins
DDM solubilized UT-EmrE and T-EmrE were evaluated using
SDS-Tricine (12%T) PAGE to identify its multimeric forms according
to its molecular weight (MW). During gel casting, a ﬁnal concen-
tration of 0.5% (v/v) trichloroethanol (TCE) was added to the gels
to visualize tryptophan residues within each protein sample. TCE
visualization was performed using UV irradiation at 302 nm
according to the method described by Ladner et al. [27]. This in-
gel TCE staining technique increased EmrE protein visibility by 62%
in comparison to conventional Coomassie staining [28]. UT-EmrE
and T-EmrE samples separated by SDS-Tricine PAGE were prepared
in incubation buffer (12% w/v SDS, 30% V/V glycerol, 0.05% CBB,
150 mM Tris–HCl pH 7.0, 100 mM DTT) from frozen stock samples
of both proteins. Both samples were mixed by stirring and
incubated at room temperature for 30 min. 20 mL of each sample
was loaded into each gel lane. The protein samples were allowed
to run for 5 h between 40 and 90 V to migrate the proteins
according to their molecular weight. BioRad low range molecular
weight (LMW) standards were used to compare the EmrE dis-
tribution on the gel. The loaded LMW standard had 1 mg of each
protein whereas both UT-EmrE and T-EmrE samples had 1.4 mg of
each protein. The gel was ﬁxed prior to imaging with Kodak 1D
software (V 3.6.5) using a gel ﬁxing solution (50% v/v methanol,
10% v/v acetic acid) for 15–20 min.
2.6. Dynamic light scattering
Measurements of dynamic Light Scattering (DLS) from dis-
persed UT-EmrE and T-EmrE proteins with and without QCC were
made in Nanoscience lab NANS at the University of Calgary. Data
were collected at Zetasizer Nano-ZS by Malvern instruments with
a He–Ne laser set to a wavelength of 633 nm and a power setting
of 4.0 mW as a light source. Software was set to collect three runs
for each sample. Size distributions on UT- and T-EmrE proteins in
terms of intensity averages were obtained using Malvern instru-
ments software V 7.02. The instrument uses Non-Invasive Back-
scatter optics (NIBS) and collects data at a ﬁxed scattering angle of
1731 that signiﬁcantly reduces multiple scattering and also scatter-
ing from dust and similar bigger particles. A quartz cell with a
10 mm path length was used to measure 300 mL of the sample.
EmrE samples were prepared in DDM solution buffer at 500:1
molar ratios of QCC:EmrE in the presence of EB, MV, CTP and TPP.
The temperature was maintained at 25 1C during all experiments.
During DLS experiments, using the intensity autocorrelation
function, the relaxation rate, Γ, can be extracted and used to
determine the translational diffusion coefﬁcient, D, of the particles
(EmrE proteins in this study) using the relation D¼Γ/Q2. Q is the
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magnitude of the scattering vector and given by
Q ¼ 4πn=λ  sin θ ð1Þ
where n refers to the refractive index of the solution, λ is the
wavelength of the scattered light, and 2θ is the scattering angle.
The viscosity of the water was taken as 8.9104 Pa s and its
refractive index as 1.33 at the measurement temperature of 25 1C.
The diffusion coefﬁcients of the dispersed particles can be deter-
mined from the intensity of the autocorrelation function measured
by DLS experiments. Hydrodynamic radius, Rh, can then be
calculated from the diffusion coefﬁcients, D, by using the Stokes–
Einstein relation
Rh ¼ kBTð Þ=6πηD ð2Þ
where kBT is the thermal energy and η is the viscosity of the
dispersion medium. For the dispersions with the presence of
multiple species, a regularized ﬁt to the DLS data was applied
since it gives details on the size distribution of the dispersed
particles. All the values, presented in this study, were obtained
using the software (V 7.02) provided by the Malvern with the
instrument.
2.7. Fluorescence spectroscopy
Fluorescence spectroscopy data were collected using a
Fluorolog-spectroﬂuorimeter from the proteins, solubilized in
buffered DDM, in the presence and absence of QCCs. Sample
spectra were collected in a 10 mm quartz cuvette at excitation
wavelengths between 275 and 305 nm to study the dynamics of
the proteins. Sets of spectra for both UT- and T-EmrE in the
presence of QCCs were also collected at an excitation wavelength
of 295 nm to speciﬁcally excite tryptophans. Emission spectra
were measured from 285 to 400 nm using double monochroma-
tors for both excitation and emission to reduce scattering artifacts.
A 5 nm band pass was used for both excitation and emission. The
wavelength collection intervals were set at 0.15 nm and integra-
tion time of 0.1 s. Each collected spectrum was an average of
3 scans for each sample. All the ﬂuorescence spectra were
collected for three biological replicates (N¼3) and the data were
averaged. Error bars were calculated as standard deviation over
three biological replicates. Experiments were conducted for the
concentration of 0.5 mM of both UT- and T-EmrE proteins. The
samples were titrated using the stock solutions of QCC in DDM
buffer for QCC:EmrE molar ratios of 0.01–500. Time between each
data set or the QCC titration increment was 10 min. The samples
were continuously mixed using a magnetic stir bar at room
temperature during the experiments. Separate sets of experiments
were also performed to ensure that all the ﬂuorescence intensity
reductions were due to quenching. For this, DDM buffer was added
to its respective protein sample without QCC to the same ﬁnal
volume of all QCC additions during the titration experiment and
no changes in emission maxima were observed. All the collected
ﬂuorescence spectra were corrected for their respective back-
ground Raman spectra. Data from the blank solutions (without
proteins) at each QCC concentration and excitation wavelength
were collected in the DDM buffer, which were than subtracted
from their relevant EmrE:QCC titration runs and excitation
wavelengths.
Fluorescence emission spectra from UT- and T-EmrE, gave
higher emission for the excitation wavelengths below 295 nm
because of the contribution from Tyrosines whereas the emission
intensity decreased beyond the excitation wavelength of 295 nm.
All the spectra, between 275 and 305 nm excitation wavelength,
were normalized and the positions of the peaks were compared
for both UT- and T-EmrE to calculate REES effects. Spectra,
collected at the excitation wavelength of 295 nm were used to
obtain ligand-binding curves for QCCs with increasing molar ratios
of QCC:EmrE. Intensity loss in the emission spectra was observed
as the ligand/QCC binding to Trp. This data against the increasing
concentration of the respective QCC was ﬁtted using Eq. (3) to
obtain the ligand-binding curves:
Specific binding¼ Bmax ligand
 
= Kdþ ligand
   ð3Þ
where the ﬂuorescence intensity change is a measure of speciﬁc
binding, Kd is an apparent dissociation constant which is the
concentration of ligand to reach half maximal binding, Bmax is
the maximum speciﬁc one-site binding or maximum number of
binding sites, [ligand] is the ligand/QCC concentration.
The percentage loss in the peak intensity (λmax average between
333 and 335 nm), caused by the Trp ﬂuorescence quenching, was
plotted against the respective QCC concentration. Data were then
ﬁtted using Eq. (3) to obtain Kd and Bmax values as discussed below.
Differences in Kd between UT- and T-EmrE were compared to
understand the equivalence of the respective puriﬁcation proto-
cols and the presence of the tag. During the calculations, inner
ﬁlter effects were essentially negligible.
3. Results
3.1. Differences between UT-EmrE and T-EmrE resistance to QCCs
In vivo QCC Kill curve resistance assays of plasmid transformed
UT-EmrE and T-EmrE in E. coli were performed to functionally
compare how well each protein version mediates EB and MV
resistance when expressed under identical conditions. The resis-
tance proﬁles of E. coli transformed with UT-EmrE or T-EmrE are
shown in Fig. 2. After 26 h of growth, the OD550 nm values
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Fig. 2. QCC resistance proﬁles of E. coli overexpressing UT-EmrE and T-EmrE. OD550 nm representing the growth of E. coli cells containing UT-EmrE (hollow triangles) or
T-EmrE (solid circles) in the presence of increasing concentrations of (a) EB and (b) MV in LB growth media. OD550 nm values were taken after 26 h of growth at 37 1C at
different concentrations of the QCCs. All QCC resistance assays were performed in triplicate (N¼3) and the error bars show the standard deviation.
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demonstrated that UT-EmrE provides more resistance to EB as
compared to T-EmrE. The proﬁle with MV was also displayed a
difference but with more variability between trials.
3.2. Puriﬁcation methods lead to differences in multimeric state
distributions
In this study, two forms of EmrE protein UT-EmrE and T-EmrE
were puriﬁed in buffered 0.08% DDM, as it is the most frequently
used detergent to reconstitute the protein and maintains a—helical
structure of membrane proteins [22]. Following afﬁnity puriﬁca-
tion, the yield of T-EmrE in 0.08% DDM buffer was determined to
be 0.1 mg/L. Organically extracted UT-EmrE preparations gave
0.07 mg/L of the proteins. Before solubilization in DDM buffer,
the yield of organically puriﬁed dried UT-EmrE was 0.24 mg/L,
indicating that only 1/3 of the proteins could be solubilized in
DDM buffer. This indicated that both tagged and untagged proteins
were solubilised in DDM to similar extents.
UT-EmrE and T-EmrE, both puriﬁed in DDM are shown in Fig. 3
in their respective lanes on SDS-Tricine 12% PAGE gel to identify
protein purity and multimeric forms. The molecular weight of UT-
EmrE and T-EmrE monomers was estimated to be 12.2 kDa and
14.4 kDa respectively. Both puriﬁcation methods provided highly
pure protein (95% based on gel detection). PAGE analysis revealed
that both proteins predominated as monomeric bands (88% UT-
EmrE and 89% T-EmrE total protein band intensity), and as less
abundant dimeric state (12% UT-EmrE and 11% T-EmrE).
The results of dynamic Light Scattering (DLS) analysis of both
protein versions with and without QCC:EmrE molar ratio of 500:1
are shown in Fig. 4. The scattering intensity distribution from UT-
EmrE showed peaks at Rh between 2–3, 60–70, and 200–250 nm.
The Rh of T-EmrE occurred between 2–3 and 100–150 nm. Multiple
intensity peaks suggest the presence of multiple species in the
dispersed samples. There is a clear difference in the amount and
population distributions in the plots in Fig. 4. Even the distribution
of the monomer peak is quite broad suggesting manifold of folding
states within the DDM micelles.
3.3. Fluorescence spectrophotometry reveals that UT-EmrE has a less
constrained structure compared to T-EmrE
Fluorescence spectrophotometry was used to evaluate the
conformational integrity of the different constructs. Considerable
differences were observed in the ﬂuorescence emission spectra
between UT-EmrE and T-EmrE. Fluorescence spectra, collected at
different excitation wavelengths between 275 and 305 nm to
select for aromatic residue emission in UT-EmrE and T-EmrE
samples as shown in Fig. 5. The spectral shape and maximum
reﬂected the environment of the aromatic residue ﬂuorophores
(due to solvent polarity and dynamics) as well as the degree of
energy transfer between ﬂuorophores of Tyr to Trp.
Fluorescence emission spectra from UT-EmrE and T-EmrE, in
response to the different excitation wavelengths can be analyzed
to see the Red-Edge Excitation Shift (REES). This is an intrinsic
property of protein ﬂuorophores and is due to slow relaxation
and re-orientation of the solvent in a viscous environment [29].
To compare the polarity and energy transfer occurring between
the aromatic residue environments of UT-EmrE and T-EmrE using
REES analysis, the position of the peak maximum (λmax) in the
emission spectrum of either protein in Fig. 5 was plotted against
the excited wavelengths as shown in Fig. 6. UT-EmrE (Fig. 6a)
demonstrated a peak at λmax333 nm, which was consistent for all
excitation wavelengths, indicating enhanced hydrophobicity in the
environment surrounding its aromatic residues. Another peak
(shoulder) at λmax348 nm can also be seen in UT-EmrE that
becomes prominent for the excitation wavelength at 300 nm
indicating some Trp exposure to aqueous environments. This
shoulder is likely a result of uncoupled energy transfer between
tryptophans of different environments.
In contrast, the REES plot of T-EmrE demonstrated a single peak
at all excitation wavelengths (Fig. 6b). T-EmrE emission spectra
were comparable in shape for λmax between 332 and 338 nm for
the excitation wavelengths between 275 and 295 nm. At the
excitation wavelength of 305 nm, the T-EmrE emission peak
completely shifted at 388 nm. This could be due to the local
solvation environment (the local residues around each of the
tryptophans) having restricted dynamics. As a comparison,
N-acetyl-tryptophan amide in the same buffer shows a uniform
single peak (355 nm) spectrum at all excitation wavelengths (data
not shown). These spectra demonstrated that neither protein has
any degree of unfolding that completely exposed their trypto-
phans to the aqueous environment. However, the environment of
ﬂuorophore solvation and dynamics were quite different between
the each version of the protein.
3.4. QCC-ligand binding reveal different UT-EmrE and T-EmrE
afﬁnities for speciﬁc ligands
The intrinsic Trp ﬂuorescence quenching upon ligand binding
was exploited to produce ligand binding curves. UT-EmrE and
T-EmrE proteins were examined in the presence of four different
QCC ligands: EB, MV, CTP and TPP. Ligand addition to either
protein leads to a decrease in the ﬂuorescence maximum emission
peak intensity of Trp, which was inﬂuenced by its environment
polarity/hydrophobicity. Changes in maximum emission peak
intensity can be plotted against the concentration of ligand
(QCC) to determine binding dissociation constant (Kd) for the
ligand. QCC ﬂuorescence quenching spectra, provided in Fig. 7,
were curve ﬁt to estimate the values of Kd and Bmax for each QCC to
each protein version. The results from this analysis indicated that
all QCCs tested quenched Trp in UT-EmrE and T-EmrE samples and
bound to both proteins (Table 2). MV and CTP had lower Kd values
for UT-EmrE as compared to the T-EmrE, whereas for EB and TPP,
Kd values were lower for T-EmrE. This shows that EB and TPP
bound more tightly to T-EmrE as compared to UT-EmrE, whereas
MV and CTP bind more tightly to the UT-EmrE.
Since ligand binding afﬁnity depended not only on the speciﬁc
arrangement of Trp at the binding site, but also depended on its
access to the binding site (Bmax). Bmax at 100% ﬂuorescence
intensity loss for each protein indicated the binding of ligand to
T-EmrE dimer
T-EmrE monomer
UT-EmrE dimer
UT-EmrE monomer
 MW 
(kDa) Std
 T-
EmrE
UT-
EmrE
 97.4
 66.2
44.4
31.0
21.5
14.4
Fig. 3. SDS-Tricine 12% PAGE analysis of 0.08% w/v DDM puriﬁed UT-EmrE and
T-EmrE, 1.4 mg of each protein was loaded in the respective lane. Low molecular
weight (LMW) Bio-Rad protein standards were used to estimate protein weights
and relative band intensity. The presence of monomeric and dimeric states are
indicated for each version of EmrE by labeled arrows.
S.J.S. Qazi et al. / Biochemistry and Biophysics Reports 1 (2015) 22–32 27
each protein in DDM. Both UT-EmrE and T-EmrE had similar Bmax
values for MV and EB (Table 2), indicating that almost all the
binding sites were occupied, as their ﬂuorescence intensity loss
was 100% (Fig. 7). 50% of UT-EmrE binding sites remained
unoccupied for TPP (Bmax50.8) in comparison to 84% of unoccu-
pied T-EmrE binding sites with TPP (Bmax16.5). In the case of CTP,
some of the binding sites also remained unoccupied for T-EmrE
(Bmax95.4) whereas for UT-EmrE they were fully occupied
(Bmax103.0).
4. Discussion
The purpose of this study was to compare structural and
functional characteristics of His6-myc epitope tagged EmrE
(T-EmrE) to untagged EmrE (UT-EmrE). Previous studies demon-
strated that the His6 tag commonly added to EmrE required a myc
epitope sequence extension before the his6 tag at the C-terminus
of the protein [5]. In this study, both versions of EmrE were
expressed in E. coli using the identical vector and cloning site
orientations and solubilized in the same detergent and buffer. Both
UT-EmrE [9,21] and T-EmrE [22] were puriﬁed using two pre-
viously published procedures involving Ni-afﬁnity chromatogra-
phy [22] to purify T-EmrE and an organic solvent extraction
reverse-phase size exclusion chromatography method [7] to
isolate UT-EmrE. Both versions of EmrE were puriﬁed in buffered
0.08% w/v DDM detergent which were 10 fold higher than the
CMC. Both puriﬁcation methods were used in this study to
compare how each method inﬂuenced the structure and folding
of EmrE using the same experimental evaluations. It also provided
an opportunity to determine the inﬂuence the tag had on EmrE
function in E. coli using in vivo drug resistance kill curve titrations
(Fig. 2). It is important to note here that attempts to isolate T-EmrE
using the organic extraction method were unsuccessful and failed
to isolate signiﬁcant amounts of T-EmrE (less than 5%) by compar-
ison of UT-EmrE (unpublished results). The lack of T-EmrE pur-
iﬁcation by organic extraction was due to the increased
hydrophilicity (11% increase compared to UT-EmrE) caused by
the addition of the tag. The addition of a protease cleavable tag to
EmrE is also in progress, but preliminary results indicated these
preparations had low cleavage efﬁciency in DDM (unpublished
results). Since the majority of studies of EmrE have maintained the
presence of the tag (as reviewed by Bay et al. [2]), it was important
for this analysis to examine the commonly used tagged version of
this protein.
This study represent the ﬁrst study to directly compare tagged
and untagged versions of EmrE puriﬁed using their speciﬁc
isolation methods and then evaluate differences in structural
arrangements by SDS-Tricine PAGE, dynamic light scattering, and
ﬂuorescence spectrophotometry. These analyses also permitted
In
te
ns
ity
 (
%
)
0
15
30
In
te
ns
ity
 (
%
)
0
15
30
In
te
ns
ity
 (
%
)
0
15
30
In
te
ns
ity
 (
%
)
0
15
30
Rh / nmRh / nm
In
te
ns
ity
 (
%
)
0
15
30
1 10 100 1000 1 10 100 1000
ErmE-TErmE-TU
EB:T-EmrE (500)EB:UT-EmrE (500)
MV:T-EmrE (500)MV:UT-EmrE (500)
CTP:T-EmrE (500)CTP:UT-EmrE (500)
TPP:T-EmrE (500)TPP:UT-EmrE (500)
Fig. 4. DLS intensity distribution of UT-EmrE and T-EmrE in the presence of QCC. Addition of QCCs did not induce any extra peak. Molar ratios for all QCC:(T, UT) EmrE
were 500:1.
S.J.S. Qazi et al. / Biochemistry and Biophysics Reports 1 (2015) 22–3228
the determination of differences in ligand binding by each protein
version. The unique differences determined for each puriﬁed EmrE
version in 0.08% w/v DDM in this study reﬂect differences in the
EmrE functionality, structure, folding, and dynamics associated to
the addition of the tag and/or by puriﬁcation method. The presence
of the tag did not alter multimerization but did appear to alter
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ligand interactions suggesting that the tag may enhance or reduce
interactions with particular ligands as shown in ﬂuorescence
analysis. This study also compared in vivo E. coli QCC resistance
assays for UT-EmrE and T-EmrE and identiﬁed a slight advantage by
UT-EmrE to mediate resistance to EB (Fig. 2). The presence of the tag
may have inﬂuenced EB transport through several means: occluding
the binding site, preventing proper multimerization, or inﬂuencing
the topological state. Although MV resistance appears to also
demonstrate enhanced resistance by UT-EmrE, the error in UT-
EmrE sample measurements may be linked to the properties of MV
itself as it is known to induce oxidative cell damage and absorb
within the 600 nm region [30,31]. These factors likely contributed to
the high variability observed in these experiments.
Evaluation of UT-EmrE and T-EmrE multimeric forms using
SDS-Tricine PAGE determined that both puriﬁcation techniques
resulted in gel-quality pure (95%) proteins. Since SDS is not
denaturing to EmrE and has demonstrated the ability to solubilize
EmrE [9] and maintain DDM-EmrE induced folding [28], PAGE
analysis permitted examination of UT-EmrE and T-EmrE multi-
meric forms [9]. Both EmrE versions predominated in as mono-
mers and to lesser extent as dimers indicating that the presence of
tag did not signiﬁcantly alter the multimer capacity of T-EmrE, in
agreement with previous studies [14,23,28]. High amounts of
T-EmrE monomer have been reported in previous experiments
that speciﬁcally examined T-EmrE multimerization [28]. There is
no clear evidence to date, that conﬁrms the monomer state of
T-EmrE or UT-EmrE are improperly folded as compared to dimers.
Studies of monomeric UT-EmrE have indicated that the monomer
was capable of binding QCC [8,10,16,29]. The high proportion of
EmrE monomer isolation by both T-EmrE and UT-EmrE from the
membranes may indicate that the dimer form is stabilized by the
presence of ligand. Our previous work examining the ligand
induced multimerization of UT-EmrE supports this mechanism
involving monomer to dimer/higher multimer formation in the
presence of ligand (as described in the review by Bay et al. [2]).
Further evaluation of UT-EmrE and T-EmrE multimeric forms
by DLS demonstrated that each protein version had three (UT-
EmrE) or two (T-EmrE) size states (Fig. 4). Rh values were used to
estimate the molecular weight of the protein, where Rh is the
radius of the sphere. For other shapes, such as plates or cylindrical
particles, the Rh strongly depends on the long axes [32,33]. In the
case for non-globular proteins such as EmrE, the shape of the
protein includes the DDM molecules around them. Because of this,
the molecular mass of UT-EmrE and T-EmrE could not be easily
estimated and the values reﬂected should be much higher than the
actual molecular mass of the proteins and its associated multi-
meric form. Although, the scattering intensity distribution, pro-
vided information on the presence and range of sizes in the
sample, the scattering caused by bigger to smaller particles creates
huge differences and the scattering intensity distribution must be
weighted to account for the bigger particles in the samples
containing multiple species. Therefore, large peaks at higher Rh
were not an indication of a larger amount of large protein/
detergent particles. Taking this into consideration, the presence
of two peaks for T-EmrE suggested that it consist of primarily two
different multimeric states whereas the third peak in UT-EmrE
may represent a higher multimeric form. Large aggregations of
EmrE have been observed previously in lipid domain experiments
where lipid type and lateral membrane pressure may play a role
[34,35].
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Table 2
A summary of the QCC binding afﬁnities of UT-EmrE and T-EmrE determined from
Trp ﬂuorescence quenching assays.
QCC T-EmrE UT-EmrE
Kd (mM) Bmax R2 Kd (mM) Bmax R2
EB 1.370.3 102.971.1 0.937 13.472.5 111.373.9 0.973
MV 178.5719.9 110.772.3 0.996 133.7723.7 107.872.9 0.972
CTP 136.5720.4 95.473.8 0.994 84.3725.8 103.075.9 0.985
TPP 4.773.7 16.572.0 0.854 16.4711.3 50.874.4 0.847
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It should be noted that the puriﬁcation methods used to isolate
UT-EmrE and T-EmrE likely affect the protein dynamics after DDM
solubilization. These solubilization condition differences may change
the associated counter ions, the amount of detergent molecules
bound by each protein, and potentially localized unfolded regions
that inﬂuence the oligomerization state [7,17,36]. Despite all these
potential inﬂuences, both UT-EmrE and T-EmrE possessed similar
monomeric and dimeric formation capacity (Figs. 2 and 3), but UT-
EmrE had greater conformational variation (Fig. 4). Because the
structure and folding of each protein may differ during the puriﬁca-
tion and solubilization procedure, tryptophans and tyrosines could
be exposed to more viscous conditions than in free solution, thereby
restricting the re-orientation of solvent and alter REES. This property
was used to probe any differences between the relative dynamics of
the ﬂuorophore environment within UT-EmrE and T-EmrE. In this
study, both UT-EmrE and T-EmrE possessed the same number of Trp
residues and T-EmrE possessed an additional Tyr within the myc-
His6 tag. Previous studies have examined the tagged version of
EmrE, and identiﬁed that only Tyr40 and Trp63 were associated
with the ligand binding site Glu14 [37]. The emission spectrum of
tagged EmrE below 295 nm excitation wavelength was also shown
to be heavily inﬂuenced by Trp63 [17]. The red-shifted emission
spectrum of T-EmrE reﬂected an environment that restricted solvent
re-orientation (Figs. 5 and 6). A red-shifted emission can be the
result of interactions of Trp and Tyr ﬂuorophores with nearby
protein residues in the binding cavity of EmrE. This suggests that
the tryptophans are in a viscous or tight folded environment and
could be indicative of a well-folded protein that restricts conforma-
tional freedom. In contrast to T-EmrE, a blue-shifted emission peak
at 333 nm was also observed in UT-EmrE and this emission maxima
did not disappear, or show reverse relaxation (Fig. 6). This type of
relaxation occurs when the emission lifetime of the ﬂuorophore is
comparable to the lifetime of solvent relaxation [38]. In the case of
UT-EmrE, the peak at 333 nm may have been due to reverse-
relaxation of the solvent caused by the sample’s longer excitation
wavelengths. Additionally, this may suggest that the tryptophans in
UT-EmrE were in an environment that was less constrained than the
tryptophans in T-EmrE.
The conformational differences between UT-EmrE and T-EmrE
observed after SDS-Trcine PAGE, DLS and ﬂuorescence REES
analyses, likely affected their afﬁnity for particular ligands
(Fig. 7). Each ligand was selected based on its chemical structure,
shape and charge. MV was the only divalent cation in this study, all
others are monovalent. MV and EB were planar in comparison to
CTP, that had a long acyl chain and acts as a surfactant. Similar to
CTP, TPP is also a surfactant but has a spherical conformation. The
binding site of EmrE is located within the transmembrane region
which incorporates a single highly conserved anionic residue,
Glu14 [5] that facilitates both Hþ and QCC antiport [39]. In
addition to Glu14, speciﬁc Trp residues like Trp63 in EmrE may
participate in a cation–pi interaction with protons (as described by
Dougherty [40]) based on Trp mutation studies of T-EmrE [17].
The structure of the QCC had different effects on the Kd and
Bmax values of T-EmrE compared to UT-EmrE. The interaction
of T-EmrE differed from UT-EmrE for CTP and TPP. CTP may
prefer to form micelles in the presence of T-EmrE, and the
saturation of CTP occurred at slightly lower Bmax values as
compared to UT-EmrE. In the case of TPP, its charged cation was
at the center of the molecule and was poorly accessible for both
UT- and T-EmrE resulting in lower Bmax values for both proteins.
TPP appeared to have more difﬁculty in binding to T-EmrE but
when it was bound TPP had a higher apparent afﬁnity with lower
site occupancy. The tighter afﬁnity by T-EmrE for EB compared to
UT-EmrE may also explain why in vivo EB resistance assays in E.
coli showed improved EB resistance by UT-EmrE expressing
strains.
5. Conclusions
Structural and functional comparison of T-EmrE and UT-EmrE
revealed differences in QCC resistance proﬁles, structural confor-
mation, and ligand binding between the different forms. It also
highlights differences in EmrE folding that may be attributed not
only to the presence of a tag but also due to differences in
puriﬁcation methodologies. Although both forms of the protein
have similar multimeric forms, bind the same ligands, and confer
resistance to the same QCCs, the differences help to explain the
frustrations over the years between different research group’s
data. Thus this work helps interpret results from previous studies
that have examined tagged and untagged forms of EmrE and other
groups studying integral membrane protein transporters or other
integral membrane proteins tagged in a similar fashion.
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